Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05711316 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The BD Liverty™ TIPS Stent Graft Study

Study acronym: ARCH
StatusActive, Not Recruiting
PhaseNot applicable
SponsorC. R. Bard
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoints added 0 → 2 primary endpoints
See other at-risk trials from C. R. Bard

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Jul 16, 2026, no change to tracked fieldsv10-v11
  2. Primary endpoint(s) modifiedv9 Show 10 more changesShow less
    • Phase changed: not specified → not applicable
    • Sponsor changed: [Redacted] to C. R. Bard
    • Trial status changed: Withheld → Active, Not Recruiting
    • Enrollment changed: None → 177
    • Trial sites expanded: 0 → 26 locations
    • Trial arms changed: 0 → 1
    • Primary completion date: Jun 23, 2025
    • Study completion date: Jan 11, 2027
    • Start date: Aug 8, 2023
    • Study title shortened, about 6 words
  3. 7 versions Re-verified since May 15, 2023, no change to tracked fieldsv2-v8
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
C. R. Bard
11 trials monitored
See 2 trials at risk
The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).
Trial Details
NCT Number NCT05711316
Lead Sponsor C. R. Bard
Conditions
(from sponsor)		 Portal Hypertension, TIPS
Related terms Ascites, Hypertension, Portal
Enrollment 177 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov